Managed Account Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Managed Account Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$344K	Buy	37,953 +16,034	+73%	+$162K	﹤0.01%	2382
2015 Q1	$284K	Buy	+21,919	New	+$287K	﹤0.01%	2365
2014 Q3	–	Sell	-453	Closed	-$6K	–	2740
2014 Q2	$6K	Sell	453 -2,396	-84%	-$25K	﹤0.01%	2603
2014 Q1	$28K	Sell	2,849 -5,328	-65%	-$66.2K	﹤0.01%	2434
2013 Q4	$109K	Buy	+8,177	New	+$99.3K	﹤0.01%	2295

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Managed Account Advisors's GNMK Position: Q2 2015 in Review

Managed Account Advisors increased its GenMark Diagnostics, Inc (GNMK) stake by 73% in Q2 2015, buying an estimated $162K and bringing the position to 37,953 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Managed Account Advisors first reported a position in GNMK in Q4 2013 and has held it in 5 quarters since. 89 funds tracked by Wall St. Rank hold GNMK as of Q2 2015.

Managed Account Advisors held 37,953 shares of GenMark Diagnostics, Inc worth $344K as of Q2 2015.
Managed Account Advisors bought 16,034 GenMark Diagnostics, Inc shares in Q2 2015, an estimated $162K.
GenMark Diagnostics, Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2382 holding.
Managed Account Advisors first reported a position in GenMark Diagnostics, Inc in Q4 2013 and has held it in 5 quarters since.
89 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.